Clinical Trial Update: Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates whether aspirin reduces recurrence of Barrett esophagus or progression to esophageal adenocarcinoma after radiofrequency a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Adenocarcinoma

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Barrett Esophagus, Esophageal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-05-01